Additional Details

  • A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease

    Dynamic Drug Advancement Ltd.
    Ajax ON. L1S 2J5
    View Details

  • A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease

    IU Health Ball Memorial Physicians Pulmonary and Critical Care Medicine
    Muncie IN. 47303-3432
    View Details

  • A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease

    Southeastern Research Center
    Winston-Salem NC. 27103-4029
    View Details

  • A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease

    Hannibal Regional Healthcare System HRMG Hannibal
    Hannibal MO. 63401-6890
    View Details

  • A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease

    Renstar Medical Research
    Ocala FL. 34470
    View Details

  • A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease

    University of Alabama at Birmingham
    Birmingham AL. 35233
    View Details

  • A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease

    El Paso Pulmonary Association Elligo PPDS
    El Paso TX. 79902-1124
    View Details

  • Feasibility of Semaglutide in Advanced Lung Disease

    University of Pennsylvania Perelman School of Medicine
    Philadelphia PA. 19104
    View Details

  • Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant

    UCLA Health Westwood Medical Plaza
    Westwood CA. 90095
    View Details

  • Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant

    Washington University School of Medicine
    St Louis MO. 63110
    View Details

  • Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant

    Advent Health
    Orlando FL. 32803
    View Details

  • Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant

    University of California Los Angeles School of Medicine
    Los Angeles CA. 90095
    View Details

  • Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant

    University of Minnesota Medical School
    Minneapolis MN. 55455
    View Details

  • Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant

    University of Texas Southwestern Medical Center
    Dallas TX. 45390
    View Details

  • Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant

    Medical University of South Carolina
    Charleston SC. 29452
    View Details

  • Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant

    Baylor Scott and White Research Institute
    Dallas TX. 75246
    View Details

  • Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant

    The Ohio State University Wexner Medical Center
    Columbus OH. 43221
    View Details

  • Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant

    University of South Florida
    Tampa FL. 33606
    View Details

  • Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant

    University of California San Diego Health
    San Diego CA. 92103
    View Details

  • Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant

    Columbia University Irving Medical Center
    New York NY. 10032
    View Details